Developer docs
API playgroundTry for free, no card

Search company profiles

Clinical Accelerator

Full company profile

uuid000jkhn

Namestring
Clinical Accelerator
Legal namestring
Clinical Accelerator
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Clinical Accelerator is a privately held, sponsor-aligned Contract Research Organization (CRO) that runs First-in-Human (FIH) and Early Human Feasibility medical device clinical trials for early-stage MedTech companies. It is headquartered in Douglas, Isle of Man, with its primary operational hub in Tbilisi, Georgia and additional country operations in Uzbekistan and Lithuania/EU. Its offering combines full-service clinical trial management — regulatory liaison, site coordination, feasibility leadership, and trial operations — with a proprietary SMPEO operating methodology, a trusted network of high-performing clinical sites across Eastern Europe and Central Asia, and an academic advisory network of cardiovascular key opinion leaders who also serve as proctors and operators. The firm also operates ecosystem assets: the annual Georgia MedTech Innovation Summit (GMIS) in Tbilisi and the associated GMIS Shark Tank pitch competition ($25,000 grand prize). Its named client base spans cardiovascular (structural heart, heart failure, mechanical circulatory support, AAA, renal denervation), oncology device, renal/wearable diagnostics, and biotech indications, with clients drawn primarily from US, Europe, Australia, Israel, and Asia.

The commercial model is professional services: quote-based, multi-year CRO contracts priced per study rather than per modular component, with prospects entering through feasibility calls to the Head of Business Development. Pricing is not publicly disclosed. Go-to-market is sales-led and direct, leveraging content marketing (blog, YouTube, LinkedIn), events (GMIS, Shark Tank), and referral/community channels cultivated through the KOL and advisory network. The company is founder-controlled (Nikolay Nikitin, Founder & CEO) with a flat organizational structure of approximately 50 clinical research professionals, no disclosed external investors, and no public revenue or funding figures.

Strategic positioning targets the specific pain points of early-stage device programs — unpredictable enrollment, slow site activation, expensive study budgets, regulatory burden, and CRO-layer overhead — by combining lean delivery in lower-cost jurisdictions with academic-grade clinical expertise in cardiovascular medicine.

Short descriptiontext

Clinical Accelerator is a sponsor-aligned CRO that runs First-in-Human and Early Feasibility clinical trials for early-stage medical device companies, delivering in Eastern Europe and Central Asia with a cardiovascular KOL network and a lean, flat delivery model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDouglas
HQ citystring
Douglas
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research organization services, medical device clinical trials, first-in-human studies, early feasibility studies, contract research organization
Industry3 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization (CRO) Services for Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1CRO Services - Clinical Trial Management
TypeProfessional Services
Description

Full-service CRO offering for First-in-Human and early feasibility medical device studies. Provides regulatory liaison, site coordination, and trial operations management. Revenue generated through professional services contracts with MedTech sponsors.

clinicalaccelerator.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Custom CRO service contracts for early-stage medical device trials
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed. Feasibility calls available for study planning.

clinicalaccelerator.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Clinical Accelerator is a sponsor-aligned Contract Research Organization (CRO) specializing in First-in-Human (FIH) and Early Human Feasibility (EFS) medical device clinical trials. It delivers full-service trial operations — regulatory liaison, site coordination, feasibility leadership, enrollment management, and monitoring — for MedTech sponsors, executing studies in Eastern Europe and Central Asia. Service delivery is anchored by the proprietary SMPEO operational methodology, a Trusted Site Network, and an Academic KOL Advisory Network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Trusted by 100+ MedTech clients globally
+1 more record
Product overview1 text field

Clinical Accelerator is a Sponsor-Aligned CRO (Contract Research Organization) specializing in First-in-Human and Early Human Feasibility medical device studies. The company operates as a unified service offering rather than a modular software platform, combining its SMPEO operational methodology with a dedicated site network across Eastern Europe and Central Asia, an academic and KOL advisory network, the Georgia MedTech Innovation Summit (GMIS) annual event, and the GMIS Shark Tank pitch competition. The core service offering is augmented by feasibility consultation services and advisory board expertise to deliver fast startup, efficient enrollment, and high-quality clinical data.

Product and service3 records
1Clinical Trial Management Services
CategoryContract Research Organization (CRO) Services
Description

Full-service CRO offering operational management for First-in-Human and Early Human Feasibility medical device studies, including regulatory liaison, site coordination, feasibility leadership, and trial operations. Target customers are MedTech sponsors globally.

2Georgia MedTech Innovation Summit (GMIS)
CategoryIndustry Event / Conference
Description

Annual invitation-only summit in Tbilisi, Georgia bringing together physicians, clinical KOLs, MedTech industry leaders, investors, and R&D experts to highlight advancements in cardiovascular and interventional medicine.

3GMIS Shark Tank Competition
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical Accelerator supports HEPTA Medical in execution and operational management of early-stage clinical trials evaluating the safety and performance of their innovative microwave ablation platform with in-situ patented tissue temperature sensor and proprietary predictive software for real-time monitoring and control of ablation procedures in early-stage cancer treatment.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical Accelerator supports the ELEVATE IV First-in-Human study for Magenta Medical's Elevate pLVAD delivering >5.4 L/min mean flow and >8.4 L/min peak flow for cardiogenic shock patients. Georgian investigators at Healthycore Clinic successfully completed this advanced mechanical circulatory support investigation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical Accelerator partners with Angiolutions to accelerate their early clinical development program for the A3-Shield implant, the first-of-its-kind device designed to stop progression of abdominal aortic aneurysms (AAA) based on pioneering research from Stanford University.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical Accelerator acts as CRO for Relief Cardiovascular's FIH trial of the Relief System, the world's first transcatheter smart implant that dynamically monitors and modulates cardiac preload and congestion in chronic heart failure patients. Full study approval granted in Georgia.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical Accelerator partners with Sutra Medical to support early clinical development of the Sutra Hemi-Valve TMVR system, a unique approach that replaces only the posterior leaflet while preserving native valve anatomy and eliminating LVOT obstruction risk.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical Accelerator supported Gradient Denervation Technologies' first-in-human study for their ultrasound-based pulmonary artery denervation system targeting pulmonary hypertension secondary to left heart disease. Study successfully launched in Georgia.

7Polares Medical
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Over three years of collaboration with Polares Medical advancing early-stage clinical investigations of the PLAR (Posterior Leaflet Augmentation and Replacement) system for mitral valve therapy. Clinical Accelerator managed early feasibility studies in Georgia, validating clinical potential and laying foundation for pivotal studies.

clinicalaccelerator.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical Accelerator collaborates with Proton Intelligence on early human feasibility study in dialysis patients for the world's first real-time, on-demand potassium monitoring wearable to prevent hyperkalemia and hypokalemia in CKD and CHF patients, under leadership of Dr. Marat Fudim at Duke University.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Nyra Medical participated in EuroPCR meeting presenting clinical insights from First-in-Human study of the CARLEN System for treating functional mitral regurgitation, with two sessions sponsored by Clinical Accelerator.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Biorasi is a mid-sized, sponsor-aligned CRO with early-phase and specialty therapeutic capabilities serving emerging biotech and MedTech companies. Its customer profile and operational model closely mirror Clinical Accelerator's positioning.

TypeDirect peer
Description

Celerion is a specialized early-phase clinical research provider with strong First-in-Human experience, particularly in cardiovascular and metabolic indications. It competes directly with Clinical Accelerator for FIH/EFS contracts from MedTech and biotech sponsors.

TypeDirect peer
Description

Premier Research is a specialty CRO with strong medical device, rare disease, and early-phase capabilities serving small and mid-sized biotech/MedTech sponsors. It is comparable in customer profile and service scope to Clinical Accelerator.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO with broad medical device, FIH, and feasibility study capabilities. It serves as a scale-driven incumbent alternative for MedTech sponsors considering Clinical Accelerator for early-stage work.

TypeBroad incumbent
Description

Medpace is a mid-to-large full-service CRO with a meaningful medical device and early-phase practice, serving biotech and MedTech sponsors globally. It represents the broad incumbent alternative that sponsors may compare Clinical Accelerator against for FIH/EFS engagements.

6NAMSA
TypeDirect peer
Description

NAMSA is the largest global CRO dedicated exclusively to medical devices, with deep FIH and Early Feasibility Study experience and a similar focus on helping MedTech sponsors navigate regulatory and clinical execution. It is the most directly comparable pure-play device CRO to Clinical Accelerator in scope and customer type.

TypeBroad incumbent
Description

Worldwide Clinical Trials is a mid-sized full-service CRO with cardiovascular and early-phase experience. It serves as a comparable alternative for sponsors evaluating FIH/EFS MedTech programs.

8CATO SMS
TypeDirect peer
Description

CATO SMS is an early-phase-focused CRO with strong First-in-Human expertise, particularly in complex and specialty indications. It competes for FIH/EFS mandates similar to those Clinical Accelerator targets.

TypeDirect peer
Description

BBK Worldwide is a patient recruitment and clinical trial enrollment specialist. Its focus on enrollment acceleration and feasibility is directly comparable to Clinical Accelerator's SMPEO model and trusted site network.

TypeDirect peer
Description

Clinipace/Ceva Clinical is a mid-sized, technology-enabled CRO serving emerging and mid-market biotech/MedTech sponsors. Its mid-market focus and adaptive service model are comparable to Clinical Accelerator's lean, sponsor-aligned approach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers16 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clinical Accelerator

Contract Research Organization (CRO) Services for Medical Devicesclinicalaccelerator.com

Clinical Accelerator is a sponsor-aligned CRO that runs First-in-Human and Early Feasibility clinical trials for early-stage medical device companies, delivering in Eastern Europe and Central Asia with a cardiovascular KOL network and a lean, flat delivery model.

What Clinical Accelerator does

Clinical Accelerator is a privately held, sponsor-aligned Contract Research Organization (CRO) that runs First-in-Human (FIH) and Early Human Feasibility medical device clinical trials for early-stage MedTech companies. It is headquartered in Douglas, Isle of Man, with its primary operational hub in Tbilisi, Georgia and additional country operations in Uzbekistan and Lithuania/EU. Its offering combines full-service clinical trial management — regulatory liaison, site coordination, feasibility leadership, and trial operations — with a proprietary SMPEO operating methodology, a trusted network of high-performing clinical sites across Eastern Europe and Central Asia, and an academic advisory network of cardiovascular key opinion leaders who also serve as proctors and operators. The firm also operates ecosystem assets: the annual Georgia MedTech Innovation Summit (GMIS) in Tbilisi and the associated GMIS Shark Tank pitch competition ($25,000 grand prize). Its named client base spans cardiovascular (structural heart, heart failure, mechanical circulatory support, AAA, renal denervation), oncology device, renal/wearable diagnostics, and biotech indications, with clients drawn primarily from US, Europe, Australia, Israel, and Asia.

The commercial model is professional services: quote-based, multi-year CRO contracts priced per study rather than per modular component, with prospects entering through feasibility calls to the Head of Business Development. Pricing is not publicly disclosed. Go-to-market is sales-led and direct, leveraging content marketing (blog, YouTube, LinkedIn), events (GMIS, Shark Tank), and referral/community channels cultivated through the KOL and advisory network. The company is founder-controlled (Nikolay Nikitin, Founder & CEO) with a flat organizational structure of approximately 50 clinical research professionals, no disclosed external investors, and no public revenue or funding figures.

Strategic positioning targets the specific pain points of early-stage device programs — unpredictable enrollment, slow site activation, expensive study budgets, regulatory burden, and CRO-layer overhead — by combining lean delivery in lower-cost jurisdictions with academic-grade clinical expertise in cardiovascular medicine.

Clinical Accelerator firmographics

Firmographics
Name
Clinical Accelerator
Legal name
Clinical Accelerator
Website
https://clinicalaccelerator.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Clinical Accelerator is a sponsor-aligned CRO that runs First-in-Human and Early Feasibility clinical trials for early-stage medical device companies, delivering in Eastern Europe and Central Asia with a cardiovascular KOL network and a lean, flat delivery model.
Ownership category
akta.pro rank

Clinical Accelerator industry classification

Industry
Product category
Contract Research Organization (CRO) Services for Medical Devices
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination

Keywords

  • Clinical research organization services
  • Medical device clinical trials
  • First-in-human studies
  • Early feasibility studies
  • Contract research organization

Where Clinical Accelerator is headquartered

Location

Headquarters

HQ city
Douglas

Offices4 records

Markets served

Clinical Accelerator business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. CRO Services - Clinical Trial Management: Full-service CRO offering for First-in-Human and early feasibility medical device studies. Provides regulatory liaison, site coordination, and trial operations management. Revenue generated through professional services contracts with MedTech sponsors.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom CRO service contracts for early-stage medical device trials

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Clinical Accelerator product offering

Product offering

Core offering

Clinical Accelerator is a sponsor-aligned Contract Research Organization (CRO) specializing in First-in-Human (FIH) and Early Human Feasibility (EFS) medical device clinical trials. It delivers full-service trial operations — regulatory liaison, site coordination, feasibility leadership, enrollment management, and monitoring — for MedTech sponsors, executing studies in Eastern Europe and Central Asia. Service delivery is anchored by the proprietary SMPEO operational methodology, a Trusted Site Network, and an Academic KOL Advisory Network.

Product overview

Clinical Accelerator is a Sponsor-Aligned CRO (Contract Research Organization) specializing in First-in-Human and Early Human Feasibility medical device studies. The company operates as a unified service offering rather than a modular software platform, combining its SMPEO operational methodology with a dedicated site network across Eastern Europe and Central Asia, an academic and KOL advisory network, the Georgia MedTech Innovation Summit (GMIS) annual event, and the GMIS Shark Tank pitch competition. The core service offering is augmented by feasibility consultation services and advisory board expertise to deliver fast startup, efficient enrollment, and high-quality clinical data.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Trial Management Services Full-service CRO offering operational management for First-in-Human and Early Human Feasibility medical device studies, including regulatory liaison, site coordination, feasibility leadership, and trial operations. Target customers are MedTech sponsors globally.
  • Georgia MedTech Innovation Summit (GMIS) Annual invitation-only summit in Tbilisi, Georgia bringing together physicians, clinical KOLs, MedTech industry leaders, investors, and R&D experts to highlight advancements in cardiovascular and interventional medicine.
  • GMIS Shark Tank Competition

Quantifiable outcome

  • Trusted by 100+ MedTech clients globally
  • +1 more outcomes

Companies that use Clinical Accelerator

Customer profile

Named customers16 records

Segments3 records

Ideal customer profiles3 records

Clinical Accelerator technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Clinical Accelerator partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • HEPTA MedicalcoreStrategic or Co-development PartnerClinical Accelerator supports HEPTA Medical in execution and operational management of early-stage clinical trials evaluating the safety and performance of their innovative microwave ablation platform with in-situ patented tissue temperature sensor and proprietary predictive software for real-time monitoring and control of ablation procedures in early-stage cancer treatment.
  • Magenta MedicalcoreStrategic or Co-development PartnerClinical Accelerator supports the ELEVATE IV First-in-Human study for Magenta Medical's Elevate pLVAD delivering >5.4 L/min mean flow and >8.4 L/min peak flow for cardiogenic shock patients. Georgian investigators at Healthycore Clinic successfully completed this advanced mechanical circulatory support investigation.
  • AngiolutionscoreStrategic or Co-development PartnerClinical Accelerator partners with Angiolutions to accelerate their early clinical development program for the A3-Shield implant, the first-of-its-kind device designed to stop progression of abdominal aortic aneurysms (AAA) based on pioneering research from Stanford University.
  • Relief CardiovascularcoreStrategic or Co-development PartnerClinical Accelerator acts as CRO for Relief Cardiovascular's FIH trial of the Relief System, the world's first transcatheter smart implant that dynamically monitors and modulates cardiac preload and congestion in chronic heart failure patients. Full study approval granted in Georgia.
  • Sutra MedicalcoreStrategic or Co-development PartnerClinical Accelerator partners with Sutra Medical to support early clinical development of the Sutra Hemi-Valve TMVR system, a unique approach that replaces only the posterior leaflet while preserving native valve anatomy and eliminating LVOT obstruction risk.
  • Gradient Denervation TechnologiescoreStrategic or Co-development PartnerClinical Accelerator supported Gradient Denervation Technologies' first-in-human study for their ultrasound-based pulmonary artery denervation system targeting pulmonary hypertension secondary to left heart disease. Study successfully launched in Georgia.
  • Polares MedicalcoreStrategic or Co-development PartnerOver three years of collaboration with Polares Medical advancing early-stage clinical investigations of the PLAR (Posterior Leaflet Augmentation and Replacement) system for mitral valve therapy. Clinical Accelerator managed early feasibility studies in Georgia, validating clinical potential and laying foundation for pivotal studies.
  • Proton IntelligencecoreStrategic or Co-development PartnerClinical Accelerator collaborates with Proton Intelligence on early human feasibility study in dialysis patients for the world's first real-time, on-demand potassium monitoring wearable to prevent hyperkalemia and hypokalemia in CKD and CHF patients, under leadership of Dr. Marat Fudim at Duke University.
  • Nyra MedicalminorStrategic or Co-development PartnerNyra Medical participated in EuroPCR meeting presenting clinical insights from First-in-Human study of the CARLEN System for treating functional mitral regurgitation, with two sessions sponsored by Clinical Accelerator.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Clinical Accelerator competitors and assessment

Company assessment

Direct peers

  • Biorasi: Biorasi is a mid-sized, sponsor-aligned CRO with early-phase and specialty therapeutic capabilities serving emerging biotech and MedTech companies. Its customer profile and operational model closely mirror Clinical Accelerator's positioning.
  • Celerion: Celerion is a specialized early-phase clinical research provider with strong First-in-Human experience, particularly in cardiovascular and metabolic indications. It competes directly with Clinical Accelerator for FIH/EFS contracts from MedTech and biotech sponsors.
  • Premier Research: Premier Research is a specialty CRO with strong medical device, rare disease, and early-phase capabilities serving small and mid-sized biotech/MedTech sponsors. It is comparable in customer profile and service scope to Clinical Accelerator.
  • NAMSA: NAMSA is the largest global CRO dedicated exclusively to medical devices, with deep FIH and Early Feasibility Study experience and a similar focus on helping MedTech sponsors navigate regulatory and clinical execution. It is the most directly comparable pure-play device CRO to Clinical Accelerator in scope and customer type.
  • CATO SMS: CATO SMS is an early-phase-focused CRO with strong First-in-Human expertise, particularly in complex and specialty indications. It competes for FIH/EFS mandates similar to those Clinical Accelerator targets.
  • BBK Worldwide: BBK Worldwide is a patient recruitment and clinical trial enrollment specialist. Its focus on enrollment acceleration and feasibility is directly comparable to Clinical Accelerator's SMPEO model and trusted site network.
  • Clinipace Worldwide (now Ceva Clinical): Clinipace/Ceva Clinical is a mid-sized, technology-enabled CRO serving emerging and mid-market biotech/MedTech sponsors. Its mid-market focus and adaptive service model are comparable to Clinical Accelerator's lean, sponsor-aligned approach.

Broad incumbents

  • IQVIA: IQVIA is the world's largest CRO with broad medical device, FIH, and feasibility study capabilities. It serves as a scale-driven incumbent alternative for MedTech sponsors considering Clinical Accelerator for early-stage work.
  • Medpace: Medpace is a mid-to-large full-service CRO with a meaningful medical device and early-phase practice, serving biotech and MedTech sponsors globally. It represents the broad incumbent alternative that sponsors may compare Clinical Accelerator against for FIH/EFS engagements.
  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized full-service CRO with cardiovascular and early-phase experience. It serves as a comparable alternative for sponsors evaluating FIH/EFS MedTech programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Clinical Accelerator social profiles

Digital presence

Clinical Accelerator financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clinical Accelerator leadership team

Management profile

Number of profiles

Profiles6 records

Clinical Accelerator funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clinical Accelerator M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Accelerator

What does Clinical Accelerator do?

Clinical Accelerator is a sponsor-aligned Contract Research Organization (CRO) specializing in First-in-Human (FIH) and Early Human Feasibility (EFS) medical device clinical trials. It delivers full-service trial operations — regulatory liaison, site coordination, feasibility leadership, enrollment management, and monitoring — for MedTech sponsors, executing studies in Eastern Europe and Central Asia. Service delivery is anchored by the proprietary SMPEO operational methodology, a Trusted Site Network, and an Academic KOL Advisory Network.

Is Clinical Accelerator a public or private company?

Clinical Accelerator is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Clinical Accelerator founded?

Clinical Accelerator was founded in -1. It employs 11 to 50 people.

Where is Clinical Accelerator based?

Clinical Accelerator is headquartered in Douglas.

How does Clinical Accelerator make money?

One revenue line is on record: CRO Services - Clinical Trial Management.

Who are Clinical Accelerator's main competitors?

Direct peers on record are Biorasi, Celerion, Premier Research, NAMSA, CATO SMS, BBK Worldwide and Clinipace Worldwide (now Ceva Clinical). Broad incumbents are IQVIA, Medpace and Worldwide Clinical Trials.

Does Clinical Accelerator have an API?

No public API is recorded for Clinical Accelerator.

What industry is Clinical Accelerator in?

Clinical Accelerator's product category is Contract Research Organization (CRO) Services for Medical Devices. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals